Teva Pharmaceutical Industries (TEVA) Net Margin Growth (3y) (2019 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3,662.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -98.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,235.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 11,401.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4,252.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -404.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -15,806.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 3,232.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -987.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 24,977.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,662.00 |
| Dec 31, 2025 | 6,468.00 |
| Sep 30, 2025 | 2,866.00 |
| Jun 30, 2025 | 3,480.00 |
| Mar 31, 2025 | 5,707.00 |
| Dec 31, 2024 | 1,752.00 |
| Sep 30, 2024 | 101.00 |
| Jun 30, 2024 | -606.00 |
| Mar 31, 2024 | 2,908.00 |
| Dec 31, 2023 | -682.00 |
| Sep 30, 2023 | 9,618.00 |
| Jun 30, 2023 | -4,392.00 |
| Mar 31, 2023 | -2,901.00 |
| Dec 31, 2022 | -5,725.00 |
| Sep 30, 2022 | -1,144.00 |
| Jun 30, 2022 | -1,174.00 |
| Mar 31, 2022 | -4,907.00 |
| Dec 31, 2021 | 3,929.00 |
| Sep 30, 2021 | -1,122.00 |
| Jun 30, 2021 | -1,458.00 |